Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
GHK-Cu: Evidence Summary
Evidence summary for GHK-Cu across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.
Back to GHK-Cu overview| Indication | Evidence Tier | Trial Count | Summary |
|---|---|---|---|
| Wound healing | Tier C | 3 | Topical application accelerates wound closure in small trials |
| Skin aging / rejuvenation | Tier C | 4 | Increases collagen synthesis and skin thickness in controlled studies |
| Hair loss | Tier D | 1 | Preclinical evidence suggests follicle stimulation; human data limited |
References (5)
- Immunostimulatory Hydrogel with Synergistic Blockage of Glutamine Metabolism and Chemodynamic Therapy for Postoperative Management of Glioblastoma. . Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2025) PMID: 39976234
- An Assessment of the Safety, Efficacy, and Tolerability of a Novel Scalp Treatment Regimen Combining a Hydroxy Acid-Based Scrub and Copper Tripeptide Serum in the Management of Seborrheic Dermatitis in Adults. . Cureus (2024) PMID: 39449909
- Microneedle-Mediated Delivery of Copper Peptide Through Skin. . Pharmaceutical research (2015) PMID: 25690343
- Using Aldara, copper peptide, and niacinamide for skin care. . Aesthetic surgery journal (2004) PMID: 19336143
- DNA- and protein-scission activities of ascorbate in the presence of copper ion and a copper-peptide complex. . Journal of biochemistry (1983) PMID: 6654857